RE: RNS Eve13 Sep 2022 11:56
I don't see much benefit from the analyst meeting, other than raising wider awareness. Perhaps that will be a catalyst in itself, but ITX has shown it has capability of gaining wider traction when it hit more than double this SP last year. That's the great thing about the share is the small free float means that small changes in shares can lead to rapid movements in the SP. However, we should also be mindful that John isn't the best public speaker and so how much analysts buy into the 'story' will be critical. It could end up being a damp squib.
To me, the bigger and more important piece was the new agreement with Croda, which whilst a formality, it's what this is likely to open up - I expect new territories, new formulations/products and greater impetus. I look forward to hearing further about this tomorrow ( I hope John is able to divulge some details which aren't under NDA).